75 filings
8-K
AMRX
Amneal Pharmaceuticals Inc - Ordinary Shares
7 May 24
Submission of Matters to a Vote of Security Holders
4:18pm
8-K
AMRX
Amneal Pharmaceuticals Inc - Ordinary Shares
3 May 24
Amneal Reports First Quarter 2024 Financial Results
6:14am
8-K
AMRX
Amneal Pharmaceuticals Inc - Ordinary Shares
1 Mar 24
Amneal Reports Fourth Quarter and Full Year 2023 Financial Results
6:13am
8-K
AMRX
Amneal Pharmaceuticals Inc - Ordinary Shares
10 Jan 24
Results of Operations and Financial Condition
7:03am
8-K
AMRX
Amneal Pharmaceuticals Inc - Ordinary Shares
15 Dec 23
Amneal Announces Move to Nasdaq
4:15pm
8-K/A
lmjle 6p8u
15 Dec 23
Financial Statements and Exhibits
4:06pm
8-K
8g8cmgxp5iv3d0f
14 Nov 23
Entry into a Material Definitive Agreement
5:04pm
8-K
vofw8t8
7 Nov 23
Amneal Reports Third Quarter 2023 Financial Results
6:21am
8-K
ni0jqn6c6 a4c6asp09b
23 Oct 23
Amneal Reports Certain Preliminary Third Quarter 2023 Financial Results
4:16pm
8-K
akkp7i
17 Oct 23
Entry into a Material Definitive Agreement
6:51am
8-K
2zw a7932pie
4 Aug 23
Amneal Reports Second Quarter 2023 Financial Results
6:22am
8-K
ngsg3dcuo137qxd3s
19 May 23
In the Court of Chancery of the State of Delaware
4:06pm
8-K
ipdxu mjhapf78ry9ijx
12 May 23
Submission of Matters to a Vote of Security Holders
4:29pm
8-K
ynt fbsu4ke4
5 May 23
Amneal Reports First Quarter 2023 Financial Results
6:17am
8-K
0736 i9lq
17 Apr 23
Amneal Reports Certain Preliminary First Quarter 2023 Financial Results
6:43am
8-K
fw9p304w4xs5frob
2 Mar 23
Amneal Reports Fourth Quarter and Full Year 2022 Financial Results
6:27am
8-K
xl8rjqlud5 cmkcq1ew
10 Jan 23
Results of Operations and Financial Condition
6:05am
8-K
l3grs8gbin
4 Nov 22
Amneal Reports Third Quarter 2022 Financial Results
6:24am
8-K
94yg5z
6 Sep 22
Amneal Appoints Gustavo Pesquin as Executive Vice President, Chief Commercial Officer – Specialty
4:15pm
8-K
f2i4j2zlvu2ihtp
5 Aug 22
Amneal Reports Second Quarter 2022 Financial Results
6:11am